Fulcrum Therapeutics (FULC) stock forecast for 2022 – 2027

Are you interested in Fulcrum Therapeutics, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the FULC stock price in 2022-2027. Is FULC a good long term stock? When should I take profit in Fulcrum Therapeutics stock? Buy or sell stock? Will FULC stock price go up? What are analysts’ forecasts for FULC stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. FULC stock returns are also predicted based on historical data.

According to our research, FULC stock is a very good long-term investment. FULC share price has been in a positive cycle for the past year. Fulcrum Therapeutics, Inc. stock trend is positive.

Fulcrum Therapeutics company info

Industry Biotechnology
Address 26 Landsdowne Street, Cambridge, MA, 02139, United States
Website https://www.fulcrumtx.com

Forecasting

52 Week High: 15.612 USD
52 Week Low: 9.71115 USD
1 Year Forecast: 14.902 USD
5 Year Forecast: 25.2776 USD

Agilent Technologies info

Market Cap: 472.8M
52 Week Change: 0.448%
52 Week High: 33.1 USD
52 Week Low: 6.85 USD
Beta: 0.624328
50 Day Moving Average: 15.67
90 Day Moving Average: 15.949
200 Day Moving Average: 19.18
Resistance Level: 12.5136
Pivot Point: 12.0978
Support Level: 11.5052
Enterprise Value: 248,837,840
Forward P/E: -4.71
Forward EPS: -2.56
Profit Margin: 0.00%
Shares Outstanding: 40,548,800
EBITDA: -3.42
Held Percent Institutions: 90.45%
PEG Ratio (5Y): -0.76
Trailing EPS: -2.34

Fulcrum Therapeutics stock forecasts for 2022-2027

DateOpen PriceClose PriceChange

Fulcrum Therapeutics Stock Forecast for 2022

March 2022 13.26 9.09 -31.45%
April 2022 8.91 9.8 9.99%
May 2022 10.1 12 18.81%
June 2022 12.12 12.87 6.19%
July 2022 13 12 -7.69%
August 2022 11.88 14.85 25%
September 2022 14.7 13.86 -5.71%
October 2022 13.86 12.24 -11.69%
November 2022 12.12 12.24 0.99%
December 2022 13.13 14.7 11.96%

Fulcrum Therapeutics Stock Forecast for 2023

January 2023 14.7 15.3 4.08%
February 2023 15.15 16.16 6.67%
March 2023 16 11.76 -26.5%
April 2023 12 11.88 -1%
May 2023 12.87 14.7 14.22%
June 2023 14.7 14.7 0%
July 2023 14.85 15.3 3.03%
August 2023 14 16.83 20.21%
September 2023 16.66 15.84 -4.92%
October 2023 15.84 15.15 -4.36%
November 2023 15.15 15.3 0.99%
December 2023 14.85 16.66 12.19%

Fulcrum Therapeutics Stock Forecast for 2024

January 2024 16.66 17.34 4.08%
February 2024 16.66 18.62 11.76%
March 2024 18.36 14.14 -22.98%
April 2024 14.14 15.15 7.14%
May 2024 15 17.17 14.47%
June 2024 16.83 18.36 9.09%
July 2024 18.18 16.66 -8.36%
August 2024 17 19.6 15.29%
September 2024 20 18.81 -5.95%
October 2024 19 17.17 -9.63%
November 2024 17.34 17.17 -0.98%
December 2024 18 19.8 10%

Fulcrum Therapeutics Stock Forecast for 2025

January 2025 19.6 19.8 1.02%
February 2025 19.8 21.42 8.18%
March 2025 20.58 17.17 -16.57%
April 2025 17 17.34 2%
May 2025 18.18 20 10.01%
June 2025 20.4 19.8 -2.94%
July 2025 20.2 20.2 0%
August 2025 20.2 21.78 7.82%
September 2025 22.44 21.21 -5.48%
October 2025 21.21 19.8 -6.65%
November 2025 20.2 20.2 0%
December 2025 19.8 22 11.11%

Fulcrum Therapeutics Stock Forecast for 2026

January 2026 22.44 22.44 0%
February 2026 21.78 24.24 11.29%
March 2026 23 18.62 -19.04%
April 2026 19.38 20.4 5.26%
May 2026 20.2 22.22 10%
June 2026 22.44 23.46 4.55%
July 2026 23.46 22 -6.22%
August 2026 22.22 24.5 10.26%
September 2026 24.75 24.48 -1.09%
October 2026 24.48 22 -10.13%
November 2026 21.78 21.56 -1.01%
December 2026 22 25.5 15.91%

Fulcrum Therapeutics Stock Forecast for 2027

January 2027 24.5 24 -2.04%